ASX - By Stock
|
CYP |
Re:
Ann: DFU Clinical Trial Enrolment Complete
|
|
Pledge
|
22 |
4.4K |
1 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
22
|
4.4K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
Ann: DFU Clinical Trial Enrolment Complete
|
|
Pledge
|
22 |
4.4K |
2 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
22
|
4.4K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
Ann: DFU Clinical Trial Enrolment Complete
|
|
Pledge
|
22 |
4.4K |
2 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
22
|
4.4K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
Ann: DFU Clinical Trial Enrolment Complete
|
|
Pledge
|
22 |
4.4K |
1 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
22
|
4.4K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
Ann: DFU Clinical Trial Enrolment Complete
|
|
Pledge
|
22 |
4.4K |
2 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
22
|
4.4K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Pledge
|
133 |
44K |
1 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
133
|
44K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Pledge
|
133 |
44K |
1 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
133
|
44K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Pledge
|
133 |
44K |
4 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
133
|
44K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Pledge
|
133 |
44K |
0 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
133
|
44K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Pledge
|
133 |
44K |
5 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
133
|
44K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Pledge
|
133 |
44K |
2 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
133
|
44K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Pledge
|
133 |
44K |
2 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
133
|
44K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Pledge
|
133 |
44K |
0 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
133
|
44K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Pledge
|
133 |
44K |
0 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
133
|
44K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Pledge
|
133 |
44K |
3 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
133
|
44K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Pledge
|
133 |
44K |
5 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
133
|
44K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Pledge
|
133 |
44K |
5 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
133
|
44K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Pledge
|
133 |
44K |
2 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
133
|
44K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Pledge
|
9.4K |
2.7M |
3 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
9.4K
|
2.7M
|
3
|
|
ASX - By Stock
|
CYP |
Re:
Ann: First Patient Treated in Phase 2 GvHD Trial
|
|
Pledge
|
61 |
10K |
1 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
61
|
10K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Pledge
|
5.0K |
2.4M |
0 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
5.0K
|
2.4M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Pledge
|
5.0K |
2.4M |
1 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
5.0K
|
2.4M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Pledge
|
5.0K |
2.4M |
0 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
5.0K
|
2.4M
|
0
|
|
ASX - By Stock
|
SYR Graphite |
Re:
General Discussion
|
|
Pledge
|
1.1K |
420K |
1 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
1.1K
|
420K
|
1
|
|
ASX - By Stock
|
SYR Graphite |
Re:
General Discussion
|
|
Pledge
|
1.1K |
420K |
0 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
1.1K
|
420K
|
0
|
|
ASX - By Stock
|
SYR Graphite |
Re:
General Discussion
|
|
Pledge
|
1.1K |
420K |
2 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
1.1K
|
420K
|
2
|
|
ASX - By Stock
|
SYR Graphite |
Re:
General Discussion
|
|
Pledge
|
1.1K |
420K |
1 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
1.1K
|
420K
|
1
|
|
ASX - By Stock
|
SYR Graphite |
Re:
General Discussion
|
|
Pledge
|
1.1K |
420K |
2 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
1.1K
|
420K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
Pledge
|
527 |
204K |
5 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
527
|
204K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
Pledge
|
527 |
204K |
7 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
527
|
204K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Placement and Entitlement Offer
|
|
Pledge
|
154 |
45K |
2 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
154
|
45K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Pledge
|
551 |
195K |
2 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
551
|
195K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Pledge
|
551 |
195K |
0 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
551
|
195K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Pledge
|
551 |
195K |
2 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
551
|
195K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Pledge
|
551 |
195K |
8 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
551
|
195K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Pledge
|
551 |
195K |
2 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
551
|
195K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Pledge
|
551 |
195K |
1 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
551
|
195K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Pledge
|
551 |
195K |
0 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
551
|
195K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Pledge
|
551 |
195K |
1 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
551
|
195K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Pledge
|
551 |
195K |
3 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
551
|
195K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Pledge
|
551 |
195K |
2 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
551
|
195K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Pledge
|
551 |
195K |
3 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
551
|
195K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Pledge
|
551 |
195K |
2 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
551
|
195K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Pledge
|
551 |
195K |
5 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
551
|
195K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
Pledge
|
534 |
195K |
1 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
534
|
195K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
Pledge
|
534 |
195K |
0 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
534
|
195K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
Pledge
|
534 |
195K |
1 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
534
|
195K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Pledge
|
551 |
195K |
1 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
551
|
195K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Pledge
|
551 |
195K |
3 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
551
|
195K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Pledge
|
551 |
195K |
5 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
551
|
195K
|
5
|
|